Food and Drug Administration
FDA extends review of Alexza product, shares fall
Jan 23, 2012 09:28 EST
(Reuters) - Alexza Pharmaceuticals Inc said U.S. health regulators extended the review date for its novel anti-psychotic treatment by three months after the company amended its approval application, sending its shares down as much as 19 percent.
U.S. consumers tell insurers to cover experimental drugs
Jan 23, 2012 09:26 EST
NEW YORK (Reuters) - When your health insurance provider denies an experimental treatment or a high-cost drug, how much are you willing to pay for the care you believe you need?
FDA: Orange juice from 5 nations have safe fungicide levels
Jan 20, 2012 11:24 EST
WASHINGTON (Reuters) - U.S. health regulators on Friday said samples of imported orange juice from five countries -- not including Brazil -- have safe levels of the fungicide carbendazim since authorities stopped some imports on January 4.
FDA: Safe fungicide levels in orange juice from 5 nations
Jan 20, 2012 11:24 EST
WASHINGTON (Reuters) - Samples of imported orange juice from five countries were found to contain safe levels of the fungicide carbendazim, U.S. regulators said on Friday, but they made no mention of samples from Brazil, which accounts for about half of all U.S. imports.
FDA clears more orange juice imports
Jan 20, 2012 11:24 EST
WASHINGTON (Reuters) - Health regulators cleared more orange juice imports from five countries after testing for the fungicide carbendazim, but made no mention of samples from top grower Brazil, which accounts for half of U.S. juice imports.
FDA clears more OJ imports, but mum on Brazil
Jan 20, 2012 11:24 EST
WASHINGTON (Reuters) - U.S. health regulators cleared more orange juice imports from five countries after testing for the fungicide carbendazim, but made no mention of samples from top grower Brazil, which accounts for half of U.S. juice imports.
FDA clears more orange juice imports
Jan 20, 2012 11:24 EST
WASHINGTON (Reuters) - Health regulators cleared more orange juice imports from five countries after testing for the fungicide carbendazim, but made no mention of samples from top grower Brazil, which accounts for half of U.S. juice imports.
EU says Novartis MS drug needs heart monitoring
Jan 20, 2012 10:20 EST
LONDON/ZURICH (Reuters) - The European Medicines Agency advised doctors to continuously monitor patients for six hours after giving them a first dose of Novartis AG's multiple sclerosis drug Gilenya, casting a shadow over the potential blockbuster product.
Drug lobby wants clearer FDA rules for diet pills
Jan 20, 2012 00:19 EST
WASHINGTON (Reuters) - The pharmaceutical industry may stop investing in medicines to treat diseases like diabetes or obesity without more explicit guidelines from U.S. regulators, the chairman of the drug trade group said on Thursday.
U.S. indoor tanning tax having mixed effects
Jan 19, 2012 16:14 EST
NEW YORK (Reuters Health) - Although a 2010 federal excise tax was meant to deter customers from using indoor tanning salons, only a minority of the businesses taking part in a new survey reported a drop in clients and most said their customers did not seem to care.
Packaging may pump-up kids' sunscreen use
Jan 19, 2012 12:27 EST
NEW YORK (Reuters Health) - Kids using a pump dispenser applied the most sunscreen in a new Australian study, but they still used less than half the amount needed for full protection.
U.S. rebuffs AstraZeneca, Bristol on diabetes drug
Jan 19, 2012 04:23 EST
LONDON (Reuters) - U.S. drug regulators need further clinical data, possibly including new clinical studies, before approving a new diabetes drug from AstraZeneca and Bristol-Myers Squibb.
Roche melanoma pill spurs growth of less harmful cancers
Jan 18, 2012 21:30 EST
CHICAGO (Reuters) - A new study helps explain why up to a third of advanced melanoma patients who take Roche Holding's pill Zelboraf develop a less deadly form of skin cancer known as cutaneous squamous cell carcinoma, and even points to a potential fix.
Roche melanoma pill spurs growth of other cancers
Jan 18, 2012 21:30 EST
CHICAGO (Reuters) - A new study helps explain why up to a third of advanced melanoma patients who take Roche Holding's pill Zelboraf develop a less deadly form of skin cancer known as cutaneous squamous cell carcinoma, and points to a potential fix.
China approves Novartis drug Lucentis
Jan 18, 2012 12:08 EST
Swiss pharmaceutical group Novartis said Wednesday it has approval in China for Lucentis, a drug against the eye disease macular degeneration.
Columbia/Watson gel did not work in U.S.: FDA review
Jan 18, 2012 12:01 EST
(Reuters) - Columbia Laboratories' and Watson Pharmaceuticals' gel for reducing the risk of premature birth did not work for U.S. women, U.S. health reviewers said on Tuesday, sending shares of the companies tumbling.
FDA approves BTG's drug for cancer toxicity
Jan 17, 2012 18:40 EST
WASHINGTON (Reuters) - U.S. health regulators gave the nod on Tuesday to a drug from British specialty drugmaker BTG Plc that helps cancer patients get rid of toxic levels of a chemotherapy treatment.
Florida's Rexall recalls vitamins over shellfish fears
Jan 17, 2012 14:25 EST
WASHINGTON (Reuters) - Florida drugstore chain Rexall Inc is recalling softgel vitamins because their mislabeled bottles contain tablets made from crustacean shells, a potential allergen, the company said.
Columbia/Watson gel did not work in U.S.: FDA review
Jan 17, 2012 14:03 EST
(Reuters) - Columbia Laboratories' gel for reducing the risk of premature birth did not work for U.S. women, U.S. health reviewers said on Tuesday, sending company shares tumbling more than 50 percent.
